Daiichi Sankyo Inc.Usage: Enhertu treats adults with multiple HER2-targeted cancers: early and metastatic HER2-positive breast cancer, HER2-low and HER2-ultralow metastatic breast cancer, HER2-mutant non-small cell lung cancer, HER2-positive metastatic gastric or gastroesophageal junction cancer, and HER2-positive unresectable or metastatic solid tumors.